Big tech firms are borrowing heavily to fund AI data centers. This surge in debt issuance is raising concerns about the bond market’s capacity. While companies remain lightly leveraged now, the need for capital is shifting from cash to public bonds. Projections show AI capital expenditure will significantly increase, requiring substantial financing.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,
June 1, 2026